Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
This multi-center parallel study is designed to study the efficacy and safety of fixed doses
of methylphenidate extended release (ER)capsules of three dose levels compared with a placebo
group in pediatric patients with Attention Deficit Hyperactivity Disorder (ADHD) who are
between 6 and 18 years old.